Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

Barraco, Nadia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.945
EU - Europa 1.113
AS - Asia 445
SA - Sud America 19
AF - Africa 8
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.937
IT - Italia 620
SG - Singapore 215
CN - Cina 169
DE - Germania 159
GB - Regno Unito 66
FI - Finlandia 63
IE - Irlanda 48
BE - Belgio 30
RU - Federazione Russa 27
IN - India 25
FR - Francia 20
SE - Svezia 17
RO - Romania 12
BR - Brasile 11
NL - Olanda 11
UA - Ucraina 9
CA - Canada 8
ES - Italia 8
HK - Hong Kong 8
AL - Albania 6
IR - Iran 6
TR - Turchia 6
CI - Costa d'Avorio 4
EG - Egitto 4
JP - Giappone 4
AT - Austria 3
AU - Australia 3
BG - Bulgaria 3
CH - Svizzera 3
PE - Perù 3
AR - Argentina 2
CL - Cile 2
EE - Estonia 2
EU - Europa 2
IQ - Iraq 2
KR - Corea 2
MO - Macao, regione amministrativa speciale della Cina 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
MK - Macedonia 1
PK - Pakistan 1
TH - Thailandia 1
Totale 4.535
Salva come PNG Salva come JPEG
Città #
Fairfield 444
Chandler 323
Ashburn 301
Seattle 196
Wilmington 185
Houston 179
Woodbridge 177
Singapore 174
Palermo 142
Cambridge 128
Ann Arbor 112
Rome 68
New York 66
Medford 61
Des Moines 49
Dublin 44
Santa Clara 44
Princeton 40
Ludwigshafen am Rhein 35
Lawrence 32
Nanjing 32
San Diego 31
Brussels 29
Kitzingen 28
Altamura 27
Milan 27
Boardman 22
Helsinki 21
Bremen 20
Beijing 18
Dearborn 17
London 16
Munich 14
Falls Church 13
Kumar 13
Jinan 12
Shenyang 11
Volla 11
Pune 10
Redwood City 10
Frankfurt am Main 9
Milazzo 9
Tappahannock 9
Tulsa 8
Aversa 7
Catania 7
Florence 7
Mascalucia 7
Phoenix 7
Tianjin 7
Turin 7
Chicago 6
Jiaxing 6
Los Angeles 6
Messina 6
Nanchang 6
San Paolo di Civitate 6
Genoa 5
Guangzhou 5
Hebei 5
Napoli 5
Ningbo 5
Norwalk 5
Tehran 5
Venice 5
Verona 5
Abidjan 4
Cagliari 4
Cairo 4
Changsha 4
Council Bluffs 4
Dallas 4
Hangzhou 4
Hanover 4
Hong Kong 4
Izmir 4
Kilburn 4
Rimini 4
Saint Petersburg 4
Alexandria 3
Bari 3
Foggia 3
Groningen 3
Lima 3
Madrid 3
Martina Franca 3
Monreale 3
Naples 3
Santa Maria a Vico 3
Siracusa 3
Tokyo 3
Zhengzhou 3
Agrigento 2
Amsterdam 2
Baghdad 2
Barcelona 2
Brzeg 2
Caserta 2
Charlottesville 2
Chengdu 2
Totale 3.454
Salva come PNG Salva come JPEG
Nome #
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 216
Dietary restriction: could it be considered as speed bump on tumor progression road? 212
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 189
A headlight on liquid biopsies: a challenging tool for breast cancer management 179
LncRNA H19, HOTAIR AND MALAT1 AS MOLECULAR BIOMARKERS IN GIST 175
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 170
Nintedanib in NSCLC: Evidence to date and place in therapy 164
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 160
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 158
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 153
Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer 143
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 138
TTF-1/p63-positive poorly differentiated NSCLC: A histogenetic hypothesis from the basal reserve cell of the terminal respiratory unit 127
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 125
Non-coding RNAs functioning in colorectal cancer stem cells 123
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 118
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 115
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 106
Liquid Biopsy in Gastrointestinal Stromal Tumor 100
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 94
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 94
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 93
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 93
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 90
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups 90
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 89
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 88
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 85
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 73
null 69
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 68
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 66
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 65
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 65
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 54
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis 53
Cancer of the Thyroid 53
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 52
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 52
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 49
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 47
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 44
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 44
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses 41
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 39
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 34
Molecular tumor board 34
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible 33
Current clinically validated applications of liquid biopsy 31
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 29
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier? 27
Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code 25
null 25
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 24
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 22
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 17
Future perspectives 12
Totale 4.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020529 0 0 0 0 0 103 62 66 81 93 101 23
2020/2021724 44 25 58 49 53 52 46 61 75 104 83 74
2021/2022655 79 113 20 20 27 49 34 29 62 57 66 99
2022/2023935 79 143 33 137 91 133 52 95 93 12 39 28
2023/2024608 29 60 36 60 32 120 86 54 16 19 9 87
2024/2025567 41 122 83 132 90 99 0 0 0 0 0 0
Totale 4.934